Michael Overstreet

Title: Michael Overstreet: Innovator in Binding Proteins

Introduction

Michael Overstreet is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of binding proteins that have potential therapeutic applications.

Latest Patents

Michael Overstreet holds a patent for "Bispecific PD-1 and TIGIT binding proteins and uses thereof." This patent relates to binding proteins, including antibodies, that specifically bind to Programmed Death-1 (PD-1) and T cell immunoreceptor with Ig and ITIM domains (TIGIT). The disclosure encompasses compositions comprising such binding proteins and nucleic acid molecules encoding them. Furthermore, it outlines methods for treating various disorders or conditions using these innovative binding proteins. He has 1 patent to his name.

Career Highlights

Michael Overstreet is currently employed at MedImmune Limited, where he continues to advance his research in the field of immunology and therapeutic proteins. His work is pivotal in developing new treatments that could improve patient outcomes in various diseases.

Collaborations

Michael collaborates with esteemed colleagues such as Yariv Mazor and Yue Wang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Michael Overstreet's work in binding proteins exemplifies the intersection of innovation and biotechnology. His contributions are paving the way for new therapeutic approaches that could significantly impact healthcare.